Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Organoid-Based Drug Sensitivity-Guided Chemotherapy for Pediatric Soft Tissue Tumors
NCT07528079Enrolling by invitation
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Apr 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial in soft tissue sarcoma (STS), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Objective Response Rate up to 2 years. Started Apr 2026; status: enrolling by invitation.
02
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT07528079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07528079.